Cargando…

Modelling in Synthesis and Optimization of Active Vaccinal Components

Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Margin, Oana-Constantina, Dulf, Eva-Henrietta, Mocan, Teodora, Mocan, Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625944/
https://www.ncbi.nlm.nih.gov/pubmed/34835765
http://dx.doi.org/10.3390/nano11113001
_version_ 1784606545508564992
author Margin, Oana-Constantina
Dulf, Eva-Henrietta
Mocan, Teodora
Mocan, Lucian
author_facet Margin, Oana-Constantina
Dulf, Eva-Henrietta
Mocan, Teodora
Mocan, Lucian
author_sort Margin, Oana-Constantina
collection PubMed
description Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative study for a therapeutic vaccine comprises the investigation of gold nanoparticles and their influence on the immune response for the annihilation of cancer cells. The model is intended to be realized using Quantitative-Structure Activity Relationship (QSAR) methods, explicitly artificial neural networks combined with fuzzy rules, to enhance automated properties of neural nets with human perception characteristics. Image processing techniques such as morphological transformations and watershed segmentation are used to extract and calculate certain molecular characteristics from hyperspectral images. The quantification of single-cell properties is one of the key resolutions, representing the treatment efficiency in therapy of colon and rectum cancerous conditions. This was accomplished by using manually counted cells as a reference point for comparing segmentation results. The early findings acquired are conclusive for further study; thus, the extracted features will be used in the feature optimization process first, followed by neural network building of the required model.
format Online
Article
Text
id pubmed-8625944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86259442021-11-27 Modelling in Synthesis and Optimization of Active Vaccinal Components Margin, Oana-Constantina Dulf, Eva-Henrietta Mocan, Teodora Mocan, Lucian Nanomaterials (Basel) Article Cancer is the second leading cause of mortality worldwide, behind heart diseases, accounting for 10 million deaths each year. This study focusses on adenocarcinoma, which is a target of a number of anticancer therapies presently being tested in medical and pharmaceutical studies. The innovative study for a therapeutic vaccine comprises the investigation of gold nanoparticles and their influence on the immune response for the annihilation of cancer cells. The model is intended to be realized using Quantitative-Structure Activity Relationship (QSAR) methods, explicitly artificial neural networks combined with fuzzy rules, to enhance automated properties of neural nets with human perception characteristics. Image processing techniques such as morphological transformations and watershed segmentation are used to extract and calculate certain molecular characteristics from hyperspectral images. The quantification of single-cell properties is one of the key resolutions, representing the treatment efficiency in therapy of colon and rectum cancerous conditions. This was accomplished by using manually counted cells as a reference point for comparing segmentation results. The early findings acquired are conclusive for further study; thus, the extracted features will be used in the feature optimization process first, followed by neural network building of the required model. MDPI 2021-11-08 /pmc/articles/PMC8625944/ /pubmed/34835765 http://dx.doi.org/10.3390/nano11113001 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Margin, Oana-Constantina
Dulf, Eva-Henrietta
Mocan, Teodora
Mocan, Lucian
Modelling in Synthesis and Optimization of Active Vaccinal Components
title Modelling in Synthesis and Optimization of Active Vaccinal Components
title_full Modelling in Synthesis and Optimization of Active Vaccinal Components
title_fullStr Modelling in Synthesis and Optimization of Active Vaccinal Components
title_full_unstemmed Modelling in Synthesis and Optimization of Active Vaccinal Components
title_short Modelling in Synthesis and Optimization of Active Vaccinal Components
title_sort modelling in synthesis and optimization of active vaccinal components
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625944/
https://www.ncbi.nlm.nih.gov/pubmed/34835765
http://dx.doi.org/10.3390/nano11113001
work_keys_str_mv AT marginoanaconstantina modellinginsynthesisandoptimizationofactivevaccinalcomponents
AT dulfevahenrietta modellinginsynthesisandoptimizationofactivevaccinalcomponents
AT mocanteodora modellinginsynthesisandoptimizationofactivevaccinalcomponents
AT mocanlucian modellinginsynthesisandoptimizationofactivevaccinalcomponents